H.A.T. Clinical Trial

(Study closed to enrollment.)

Home Automated External Defibrillator Trial - H.A.T.

Purpose:

To determine if a layman's use of an Automated External Defibrillator (AED) will improve survival in the event of sudden cardiac arrest in the home.

Principal Investigator:

Igor Singer MD, FRACP, FACP, FACC, FACA
Executive Medical Director, Cardiovascular Services
Clinical Professor of Medicine and Surgery , University of Illinois

For More Information Contact:

Sue Copp, MS, RN
(309) 672-4674
suecopp@mmci.org

Summary:

This trial will compare 2 different ways of handling sudden cardiac arrest in the home. Participants must be 18 years or older and have a history of anterior myocardial infarction (MI or heart attack). In one group, someone living in the patient's household (spouse/companion) will be trained in emergency medical system (EMS) access and CPR. In the other group, the companion will be trained in EMS access, CPR, and the use of an AED. Participants will be followed for at least 2 years and as long as 4 years (depending on when enrolled in the study). To be eligible both the patient and a spouse/companion must agree together.

This study is now closed to enrollment. H.A.T. is funded by the United States National Institutes of Health (NIH). For more information click on clinical trials.gov.